White discharge

Phase 2

• Conditions: Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

• Registration Number: CTRI/2020/11/028925
• Lead Sponsor: Parul Institute of Ayurved

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Married willing and cooperative women

2)Age between 20 years to 55 years.

3)The patients having clinical signs and symptoms of Yonigata Swetastrava i.e. features of white discharge with itching/ any abnormal smell/ swelling/redness.

4) Detection of pathogen by wet vaginal smear examination including any features either one/two/three/all.

5)Abstinence from sexual intercourse during study period or husband willing to use condoms during study period.

6)Hb > 7 gms%

Exclusion Criteria

1)Unmarried women

2)Age below 20 years and above 55 years

3)Pregnant women, patient with IUCD, Contraceptive pills

4)Patients suffering from Tuberculosis, HIV, VDRL, DM, TORCH infection, Cervical erosion, prolapse, polyp, unexplained vaginal bleeding, Genital malignancy and Congenital and any other organic pathologies of reproductive tract.

5)PID-lower abdominal pain, leucorrhoea, rebound abdominal tenderness, dyspareunia, tenderness of uterus or fornics, fever, leukocytosis (at least 3 criteria positive)

6)Use of antibiotics or local vaginal formulation within the previous month

7)Hemoglobin less than 7 gm%

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amount of leucorrhoea and Local Symptom scoring for â??swelling, itching,redness etc-Timepoint: 7 days of treatment

Secondary Outcome Measures

Name	Time	Method
Amount of leucorrhoea and Local Symptom scoring for â??swelling, itching,redness etc-Timepoint: after 1 month of treatment